1. US Food and Drug Administration, Center for Drug Evaluation and Research. Listing of Approved Oncology Drugs with Approved Indications. ; 2006.
2. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N Engl J Med,2006
3. International Commission on Radiation Units and Measurements (ICRU), Prescribing, Recording, and Reporting Photon Beam Therapy. ICRU Report 50. Washington, DC; 1993.
4. Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining?;Peréz-Soler;J Clin Oncol,2005
5. National Cancer Institute. Cancer Therapy Evaluation Program. Common terminology criteria for adverse events, v3.0 (CTCAE). .